lamotrigine has been researched along with trimethoprim, sulfamethoxazole drug combination in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Cazzaniga, S; Citterio, A; Diphoorn, J; Gamba, C; Naldi, L; Rivolta, AL; Schroeder, J; Vighi, GD | 1 |
| Baylor, AE; Dolman, HS; Faris, J; Isaacson, A; Tyburski, JG; White, MT; Wilson, J | 1 |
| Chodosh, J; Kwan, J; Rashad, R; Saeed, HN; Saeed, S; Shanbhag, SS | 1 |
3 other study(ies) available for lamotrigine and trimethoprim, sulfamethoxazole drug combination
| Article | Year |
|---|---|
Incidence, causative factors and mortality rates of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in northern Italy: data from the REACT registry.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Allopurinol; Child; Child, Preschool; Female; Humans; Incidence; Italy; Lamotrigine; Male; Middle Aged; Mortality; Registries; Stevens-Johnson Syndrome; Triazines; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2016 |
A Cautionary Tale of Etanercept Use in Patients With Toxic Epidermal Necrolysis.
Topics: Adult; Aged; Etanercept; Fatal Outcome; Female; Humans; Immunosuppressive Agents; Lamotrigine; Stevens-Johnson Syndrome; Trimethoprim, Sulfamethoxazole Drug Combination | 2021 |
Chronic ocular complications in lamotrigine vs. trimethoprim-sulfamethoxazole induced Stevens-Johnson syndrome/toxic epidermal necrolysis.
Topics: Cross-Sectional Studies; Humans; Lamotrigine; Retrospective Studies; Stevens-Johnson Syndrome; Trimethoprim, Sulfamethoxazole Drug Combination | 2021 |